Save information for later
Sign Up

Learn About Congenital Hemolytic Anemia

View Main Condition: Anemia

What is the definition of Congenital Hemolytic Anemia?
Congenital hemolytic anemia is a genetic disorder in which there is a significant reduction in red blood cells in the blood that are fit to carry oxygen due to an abnormality in how the cells are formed. There are several types of congenital hemolytic anemias, including sickle cell disease (SCD), hereditary spherocytosis, and pyruvate kinase deficiency.
What are the symptoms of Congenital Hemolytic Anemia?
Symptoms of congenital hemolytic anemia may include fatigue, paleness, fever, mental confusion, dizziness, difficulty breathing on exertion, dark urine, yellowing of the skin and whites of eyes (jaundice), enlarged liver or spleen, kidney failure, pain in the extremities, heart murmur, and irregular heartbeat.
Not sure about your diagnosis?
Check Your Symptoms
What are the current treatments for Congenital Hemolytic Anemia?
Treatment for congenital hemolytic anemia depends on the severity of the disorder and may include blood transfusions, corticosteroids, intravenous immune globulin (IVIG), blood exchange transfusion, splenectomy, and immunosuppressive therapy.
Who are the top Congenital Hemolytic Anemia Local Doctors?
Nirmish R. Shah
Elite in Congenital Hemolytic Anemia
Hematology | Pediatrics
Elite in Congenital Hemolytic Anemia
Hematology | Pediatrics

Duke Adult Comprehensive Sickle Cell Center - Clinic 2N

40 Duke Medicine Cir, 
Durham, NC 
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Nirmish Shah is a Hematologist and a Pediatrics provider in Durham, North Carolina. Dr. Shah is rated as an Elite provider by MediFind in the treatment of Congenital Hemolytic Anemia. His top areas of expertise are Sickle Cell Disease, Congenital Hemolytic Anemia, Hemoglobinopathy, Hemolytic Anemia, and Bone Marrow Transplant. Dr. Shah is currently accepting new patients.

Elite in Congenital Hemolytic Anemia
Family Medicine
Elite in Congenital Hemolytic Anemia
Family Medicine

LG Health Physicians Family Medicine Leola

146 E Main Street, 
Leola, PA 
Languages Spoken:
English
Accepting New Patients

John Wood is a primary care provider, practicing in Family Medicine in Leola, Pennsylvania. Dr. Wood is rated as an Elite provider by MediFind in the treatment of Congenital Hemolytic Anemia. His top areas of expertise are Congenital Hemolytic Anemia, Hemoglobinopathy, Anemia, Hemolytic Anemia, and Splenectomy. Dr. Wood is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Marilyn J. Telen
Elite in Congenital Hemolytic Anemia
Elite in Congenital Hemolytic Anemia

Duke Adult Comprehensive Sickle Cell Center - Clinic 2N

40 Duke Medicine Cir, 
Durham, NC 
Languages Spoken:
English, French, Russian
Accepting New Patients
Offers Telehealth

Marilyn Telen is a Hematologist in Durham, North Carolina. Dr. Telen is rated as an Elite provider by MediFind in the treatment of Congenital Hemolytic Anemia. Her top areas of expertise are Sickle Cell Disease, Congenital Hemolytic Anemia, Hemoglobinopathy, and Hemolytic Anemia. Dr. Telen is currently accepting new patients.

What are the latest Congenital Hemolytic Anemia Clinical Trials?
Repeat Peripheral Blood Stem Cell Transplantation for Patients With Sickle Cell Disease or Beta-Thalassemia and Falling Donor Myeloid Chimerism Levels

Background: Sickle cell disease can often be treated with blood stem cell transplants. But for some people the disease returns. This study will give a second transplant to people whose disease has returned but still have some donor cells in their body.

Match to trials
Find the right clinical trials for you in under a minute
Get started
ATHN Transcends: A Natural History Cohort Study of the Safety, Effectiveness, and Practice of Treatment in People With Non-Neoplastic Hematologic Disorders

Summary: In parallel with the growth of ATHN's clinical studies, the number of new therapies for all blood disorders is increasing significantly. Some of the recently FDA-approved therapies for congenital and acquired hematologic conditions have not yet demonstrated long-term safety and effectiveness beyond the pivotal trials that led to their approval. In addition, results from well controlled, pivotal st...